Farides Saavedra
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Polyfunctional antibody signature defines protection in Andes hantavirus survival.
Journal: Frontiers in immunology
Published: October 23, 2025
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.
Journal: medRxiv : the preprint server for health sciences
Published: April 20, 2022
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 26, 2021
Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.
Journal: Immunology
Published: November 25, 2020
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
Journal: Frontiers in immunology
Published: July 01, 2020
Differential CD4 T Regulatory Cell Phenotype Induced by Andes Hantavirus Glycoprotein.
Journal: Frontiers in cellular and infection microbiology
Published: March 26, 2020
Correlation between clinical and laboratory criteria of suspected Hantavirus cases and the results of the reference diagnostic technique
Journal: Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia
Published: November 02, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026